These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2328889)

  • 1. [Effect of Algicon suspension on postprandial esophageal pH in acid gastro-esophageal reflux].
    Ducrotté P; Fournet J; Gosselin A; de Maynard C
    Gastroenterol Clin Biol; 1990; 14(2):190-1. PubMed ID: 2328889
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of gastro-oesophageal reflux disorders. Algicon: a product overview.
    Gimbol MJ
    Br J Clin Pract Suppl; 1989 Feb; 66():2-4; discussion 35-6. PubMed ID: 2511918
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of gastro-oesophageal reflux disorders. Focus on algicon. Proceedings of a symposium. Sheffield, UK, 17th September 1988.
    Br J Clin Pract Suppl; 1989 Feb; 66():1-64. PubMed ID: 2511915
    [No Abstract]   [Full Text] [Related]  

  • 4. Algicon in the management of gastro-oesophageal reflux.
    Lambert JR; Korman MG; Nicholson L
    Br J Clin Pract Suppl; 1989 Feb; 66():56-8; discussion 61-4. PubMed ID: 2556177
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of gastro-esophageal reflux using a potable gaviscon suspension].
    Guerre J; Neuman M; Bouchet J
    Med Chir Dig; 1982; 11(4):289-95. PubMed ID: 6287126
    [No Abstract]   [Full Text] [Related]  

  • 6. Gastro-oesophageal pH measurements during reflux induced by provocative tests.
    Baldi F; Longanesi A; Ferrarini F; Ragazzini M; Michieletti G
    Br J Clin Pract Suppl; 1989 Feb; 66():10-4; discussion 35-6. PubMed ID: 2511916
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of gastro-oesophageal reflux in volunteers assessed by ambulatory pH and gamma monitoring after treatment with either Liquid Gaviscon or Algicon Suspension.
    Washington N; Greaves JL; Iftikhar SY
    Aliment Pharmacol Ther; 1992 Oct; 6(5):579-88. PubMed ID: 1420749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux.
    Ward AE
    Br J Clin Pract Suppl; 1989 Feb; 66():52-5; discussion 61-4. PubMed ID: 2556176
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative study of Algicon suspension and magnesium trisilicate mixture in the treatment of reflux dyspepsia of pregnancy.
    Lang GD; Dougall A
    Br J Clin Pract Suppl; 1989 Feb; 66():48-51; discussion 61-4. PubMed ID: 2556175
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.
    Corvaglia L; Aceti A; Mariani E; De Giorgi M; Capretti MG; Faldella G
    Aliment Pharmacol Ther; 2011 Feb; 33(4):466-70. PubMed ID: 21158879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with sodium alginate of gastroesophageal reflux disease in childhood: efficacy and tolerance assessment].
    Maestri L
    Pediatr Med Chir; 2001; 23(3-4):187-9. PubMed ID: 11723856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes.
    Dettmar PW; Sykes J; Little SL; Bryan J
    Int J Clin Pract; 2006 Mar; 60(3):275-83. PubMed ID: 16494641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacologic efficacy of sodium alginate suspension on gastro-esophageal reflux in infants and children].
    Le Luyer B; Mougenot JF; Mashako L; Chapoy P; Olives JP; Morali A; Chevallier B; Ginies JL; Dupont C; Dagorne M
    Arch Fr Pediatr; 1990 Jan; 47(1):65-8. PubMed ID: 2322080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alginate-raft preparations in the treatment of acid reflux and heartburn (literature review)].
    Mandel KG; Deggi BP; Brodi DA; Jeykobi GI
    Eksp Klin Gastroenterol; 2008; (4):64-77. PubMed ID: 19145905
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].
    Uspenskiĭ IuP; Pakhomova IG; Bubiakina VN
    Eksp Klin Gastroenterol; 2008; (1):96-101. PubMed ID: 19145860
    [No Abstract]   [Full Text] [Related]  

  • 16. [A successful treatment of gastro-oesophageal reflux in infancy with Gaviscon].
    Gross-Kieselstein E; Branski D; Abrahamov A
    Harefuah; 1975 Oct; 89(7):327-9. PubMed ID: 171200
    [No Abstract]   [Full Text] [Related]  

  • 17. [Peptic esophagitis, complication of gastro-esophageal reflux. A new treatment: Gaviscon].
    Monin E; Chevrel B
    Med Chir Dig; 1975; 4 suppl 2():67-71. PubMed ID: 1219249
    [No Abstract]   [Full Text] [Related]  

  • 18. Twenty-four-hour oesophageal pH monitoring of reflux episodes: effect of Algicon.
    Devis G; de Rop H; Peters O
    Br J Clin Pract Suppl; 1989 Feb; 66():15-7; discussion 35-6. PubMed ID: 2511917
    [No Abstract]   [Full Text] [Related]  

  • 19. Alginate-antacid in the reduction of gastro-oesophageal reflux.
    Stanciu C; Bennett JR
    Lancet; 1974 Jan; 1(7848):109-11. PubMed ID: 4130309
    [No Abstract]   [Full Text] [Related]  

  • 20. Ranitidine, cimetidine, antacids, and gastro-oesophageal reflux: results of a 20-hour oesophageal pH study.
    Desechalliers JP; Galmiche JP; Touchais JY; Denis P; Colin R
    Int J Clin Pharmacol Res; 1984; 4(3):217-22. PubMed ID: 6092288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.